Furthermore, loss of Olfm4+ ISCs in GVHD was more severe in these IFNγRΔIEC recipients lacking IFNγR expression in the intestinal epithelium than it was in WT control BMT recipients (Fig. 2l). The gene discussed is IFNGR1; the disease is graft versus host disease.